New pill shows promise for debilitating endometriosis pain
NCT ID NCT06076486
Summary
This study tested whether a medication called elagolix could safely reduce pain for women with moderate to severe endometriosis. Over 200 premenopausal women were randomly assigned to receive either the real drug or a placebo pill for 12 weeks. The main goal was to see if the drug was better than the placebo at reducing menstrual and non-menstrual pelvic pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Conditions
Explore the condition pages connected to this study.